BioVaxys Technology
(OTC) BVAXF
BioVaxys Technology Financials at a Glance
Market Cap
$4.37MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
CA$0.00
Net Income (TTM)
-CA$6.04M
EPS (TTM)
-$0.16
P/E Ratio
-0.94
Dividend
$0.00
Beta (Volatility)
0.12 (Low)
Dividend
$0.00
Beta (Volatility)
0.12 (Low)
Price
$0.15
Volume
9,153
Open
$0.11
Price
$0.15
Volume
9,153
Open
$0.11
Previous Close
$0.15
Daily Range
$0.08 - $0.15
52-Week Range
$0.02 - $0.29
Estimated Earnings Date
Mar 31, 2025
Dividend
$0.00
Beta (Volatility)
0.12 (Low)
Price
$0.15
Volume
9,153
Open
$0.11
Previous Close
$0.15
Daily Range
$0.08 - $0.15
52-Week Range
$0.02 - $0.29
Estimated Earnings Date
Mar 31, 2025
BVAXF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout BioVaxys Technology
Industry
Pharmaceuticals
Sector
Health CareCEO
James Christopher Passin
Website
www.biovaxys.comHeadquarters
Etobicoke, ON V6C 1L6, CA
BVAXF Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
121.88%
Return on Capital
N/A
Return on Assets
-237.77%
Earnings Yield
-1.06%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$4.37MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
29.15M
Volume
9.15K
Avg. Volume
88.37K
Financials (TTM)
Gross Profit
CA$0.00
Operating Income
-CA$4.85M
EBITDA
-CA$4.65M
Operating Cash Flow
-CA$2.97M
Capital Expenditure
CA$0.00
Free Cash Flow
-CA$4.03M
Cash & ST Invst.
CA$4.08K
Total Debt
CA$133.72K
BioVaxys Technology Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
CA$0.00
N/A
Gross Profit
CA$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$4.37MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$1.46M
N/A
Employees
3
N/A
Net Income
-CA$910.06K
+23.3%
EBITDA
-CA$656.85K
+18.1%
Quarterly Fundamentals
Total Cash
CA$4.08K
-99.2%
Total Debt
CA$133.72K
+64.7%
Accounts Receivable
CA$0.00
-100.0%
Inventory
CA$0.00
N/A
Long Term Debt
CA$0.00
N/A
Short Term Debt
CA$133.72K
+64.7%
Return on Assets
-2.38%
N/A
Return on Invested Capital
92.14%
N/A
Free Cash Flow
-CA$1.06M
-156.3%
Operating Cash Flow
-CA$1.06M
-156.3%